Kirwan, Annie (2012) Characterisation of the role of human Evolutionary Conserved Signalling Intermediate in Toll (ECSIT) in Mitogen Activated Protein Kinase (MAPK) signalling. Masters thesis, National University of Ireland Maynooth.

Preview

Download (8MB) | Preview

Abstract

Evolutionarily conserved signalling intermediate in Toll pathways (ECSIT) was identified orginally as a TNF receptor associated factor 6 (TRAF6) interacting partner. The murine homolog mECSIT has been shown to be involved in NFκB, MAPK, BMP and mitochondrial signalling. To date there is no work published on the human homolog, hECSIT. In this thesis, I present data indicating that hECSIT is involved in NFκB, BMP and MAPK signalling. There is a striking difference in the role of hECSIT and mECSIT in the activation of inflammatory transcription factors NFκB, ELK-1 and AP-1; with mECSIT augmenting their activation and hECSIT having an inhibitory role. In addition I demonstrate that hECSIT specifically targets the p42/44 branch of MAPK signalling. Suppression of endogenous hECSIT results in increased basal and proinflammatory induced phosphorylation of p42/44 but not JNK or p38. Thus, hECSIT signalling represents a novel means of regulating p42/44 and its downstream targets.

Item Type:	Thesis (Masters)
Keywords:	human Evolutionary Conserved Signalling Intermediate Toll; ECSIT; Mitogen Activated Protein Kinase; MAPK; signalling;
Academic Unit:	Faculty of Science and Engineering > Research Institutes > Institute of Immunology
Item ID:	5670
Depositing User:	IR eTheses
Date Deposited:	13 Jan 2015 17:24
Funders:	IRCSET
URI:
Use Licence:	This item is available under a Creative Commons Attribution Non Commercial Share Alike Licence (CC BY-NC-SA). Details of this licence are available here

Repository Staff Only(login required)

Item control page

Downloads

Origin of downloads